Blood test may spare patients painful bone marrow biopsy

NCT ID NCT07562542

Recruiting now Diagnosis Sponsor: The First Affiliated Hospital of Soochow University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether a simple blood test can accurately diagnose systemic mastocytosis, a rare disease where too many mast cells build up in the body. Currently, diagnosis requires an invasive bone marrow biopsy. The blood test looks for a specific genetic mutation (KIT-D816V) using a highly sensitive method called ddPCR. If it works, it could make diagnosis easier and less painful for patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could replace invasive bone marrow biopsies with a simple blood test for diagnosing systemic mastocytosis.
What could go wrong: This is a small, early-stage observational study with only 50 participants, so results may not apply to all patients. The blood test might not be as accurate as the standard biopsy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIT D816V MUTATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Mastocytosis, Systemic systemic mastocytosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

KIT D816V MUTATION SYSTEMIC MASTOCYTOSIS

Contacts and locations

Locations

The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology
RECRUITING

Suzhou, Jiangsu, 215000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.